9 out of 10
new antibiotics in
the last decade
have been touched
by us.

Here’s why.

People choose us because we reduce the risk of developing antimicrobials.

We do this by discovering the right dose, interval, and duration for your drug — whether it may be an antibacterial, antifungal, antiviral, or biologic — and we do it better than anyone else in the world.

A bold claim, for sure, but consider these facts.

We own great labs.

To get great results, you need great labs.

But even the greatest of labs are useless if you can’t use them when you need to.

That’s why we've heavily invested in our computer hardware, drug assay, and wet labs. In fact, we have our own in vitro and in vivo translational medicine laboratories.

This allows us to get great results while hitting deadlines others can’t.

We go from benchtop to bedside.

You make drugs to treat people, not petri dishes.

So why stop in the lab?

We are the only translational medicine group that takes your antimicrobial from the laboratory all the way to the patient. This is because decisions based on clinical and preclinical data beat either alone — as proven by our results.

To us, this is the only way to do it.

We go beyond number crunching.

Some people think that all you need for good translational medicine is for-hire statisticians.

We strongly disagree.

To make the best decisions, you have to integrate not only statistics, but pharmacology and medicine as well. ICPD is a group of Pharm.D., Ph.D., and M.D. scientists each commonly bound by a personal devotion to translational medicine.

It's for this reason that we've been invited to be a part of so many government and company advisory panels.

This is our singular focus. It's all we do.

Bottom line: We lower your risk.